Agilon Health (AGL) Equity Income (2022 - 2026)

Agilon Health has reported Equity Income for 5 years, with the latest figure at $11.7 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Income fell 7.41% year-over-year to $11.7 million; the trailing twelve-month figure through Mar 2026 stood at -$2.8 million (down 112.62% YoY), and the FY2025 full-year result was -$1.8 million, down 112.24% from the prior year.
• Equity Income for Q1 2026 stood at $11.7 million, up from -$33.1 million in the prior quarter.
• The five-year high for Equity Income was $14.7 million in Q3 2023, with the low at -$33.1 million in Q4 2025.
• Historically, Equity Income has averaged $3.0 million across 5 years, with a median of $5.7 million in 2024.
• The largest YoY upside for Equity Income was 541.57% in 2025 against a maximum downside of 1126.87% in 2025.
• Agilon Health's Equity Income stood at $7.2 million in 2022, then plunged by 210.64% to -$8.0 million in 2023, then surged by 66.4% to -$2.7 million in 2024, then tumbled by 1126.87% to -$33.1 million in 2025, then jumped by 135.5% to $11.7 million in 2026.
• The last three Equity Income figures came in at $11.7 million (Q1 2026), -$33.1 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.